StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO – Get Rating) in a research note published on Thursday. The brokerage issued a sell rating on the medical device company’s stock. NASDAQ:NURO traded up $0.13 during mid-day trading on Thursday, reaching $4.29. The stock had a trading volume of 79,362 shares, compared to its average volume […]
WOBURN, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 fourth quarter and full.
Antifungal Drugs Market Size to Hit USD 13 17 Billion and Grow at 3 3% CAGR by 2027; Growth of Hematopoietic Stem Cell Transplantation to Spur Demand: Fortune Business Insights™ yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.